Stay updated on Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    0.5%
    Check dated 2025-06-19T19:49:45.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T11:16:12.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.8%
    Check dated 2025-05-29T05:57:54.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page has updated the study's contact information and increased the number of study locations from 221 to 225, while also removing outdated dates and locations.
    Difference
    17%
    Check dated 2025-05-22T02:26:55.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T13:52:50.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on non-small cell lung cancer, while adding new drug names and a revision number.
    Difference
    11%
    Check dated 2025-04-16T01:48:27.000Z thumbnail image

Stay in the know with updates to Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.